PetMed Express - PETS Stock Forecast, Price & News

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for PetMed Express in the last twelve months. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" PETS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PETS, but not buy additional shares or sell existing shares.
View PETS analyst ratings or view top-rated stocks.

3 Wall Street analysts have issued twelve-month price targets for PetMed Express' stock. Their PETS share price forecasts range from $19.00 to $32.00. On average, they predict the company's share price to reach $26.33 in the next twelve months. This suggests a possible upside of 11.8% from the stock's current price.
View analysts price targets for PETS or view top-rated stocks among Wall Street analysts.

PetMed Express' stock was trading at $25.26 at the beginning of 2022. Since then, PETS stock has decreased by 6.7% and is now trading at $23.56.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Monday, October 24th 2022.
View our PETS earnings forecast.

PetMed Express, Inc. (NASDAQ:PETS) posted its quarterly earnings results on Monday, July, 25th. The company reported $0.14 earnings per share for the quarter, missing analysts' consensus estimates of $0.25 by $0.11. PetMed Express had a net margin of 7.36% and a trailing twelve-month return on equity of 13.77%. During the same quarter in the prior year, the business earned $0.26 EPS.

PetMed Express announced a quarterly dividend on Monday, July 25th. Shareholders of record on Friday, August 12th will be paid a dividend of $0.30 per share on Friday, August 19th. This represents a $1.20 annualized dividend and a dividend yield of 5.09%. The ex-dividend date of this dividend is Thursday, August 11th.
Read our dividend analysis for PETS.

PetMed Express (NASDAQ:PETS) pays an annual dividend of $1.20 per share and currently has a dividend yield of 5.10%. PETS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company has been increasing its dividend for 13 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 125.00%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, PETS will have a dividend payout ratio of 122.45% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for PETS.

5 employees have rated PetMed Express Chief Executive Officer Mendo Akdag on Glassdoor.com. Mendo Akdag has an approval rating of 46% among the company's employees. This puts Mendo Akdag in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other PetMed Express investors own include Intel (INTC), NVIDIA (NVDA), AT&T (T), Cisco Systems (CSCO), Alibaba Group (BABA), Gilead Sciences (GILD), Advanced Micro Devices (AMD), Verizon Communications (VZ), Netflix (NFLX) and Micron Technology (MU).

PetMed Express trades on the NASDAQ under the ticker symbol "PETS."

PetMed Express' stock is owned by many different retail and institutional investors. Top institutional investors include Renaissance Technologies LLC (5.61%), State Street Corp (4.77%), ProShare Advisors LLC (3.77%), Personal Capital Advisors Corp (2.07%), Millennium Management LLC (1.20%) and Northern Trust Corp (1.07%). Insiders that own company stock include Bruce S Rosenbloom, Gian Fulgoni, Menderes Akdag and Ronald J Korn.
View institutional ownership trends.

Shares of PETS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PETS stock can currently be purchased for approximately $23.56.

PetMed Express (NASDAQ:PETS) has a market capitalization of $494.50 million and generates $273.42 million in revenue each year. The company earns $21.10 million in net income (profit) each year or $0.96 on an earnings per share basis.

The company employs 219 workers across the globe.

PetMed Express was founded in 1996.

PetMed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The official website for the company is www.1800petmeds.com. The company can be reached via phone at (561) 526-4444, via email at investor@petmeds.com, or via fax at 561-526-4445.